Latest Breaking News On - Company xrx - Page 1 : comparemela.com

XORTX Therapeutics Inc : XORTX Submits a New Patent for the Treatment of Chronic Kidney Disease

XORTX Therapeutics Inc : XORTX Submits a New Patent for the Treatment of Chronic Kidney Disease
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesAllen davidoffNick rigopulosTherapeutics incCompany xrxSublingual formulationsXanthine oxidase inhibitorsBridging pharmacokinetic studyKidney diseasePolycystic kidney diseaseNat rev disNat rev nephrolRespiratory viral

XORTX Therapeutics (XRTX) Submits Orphan Drug Designation Application to the EMA to Treat Progressive Kidney Disease

XORTX Therapeutics (XRTX) Submits Orphan Drug Designation Application to the EMA to Treat Progressive Kidney Disease
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesOiipriya dasNick rigopulosAllen davidoffVenture exchangeCommittee for orphan medicinal productsEuropean medicines agencyXortx therapeutics incCompany xrxTherapeutics incOrphan drug designationOrphan medicinal productsDrug administrationRespiratory viralKidney diseasePolycystic kidney disease

XORTX Therapeutics Inc (XRTX) Receives FDA Orphan Drug Designation to Treat Autosomal Dominant Kidney Disease

XORTX Therapeutics Inc (XRTX) Receives FDA Orphan Drug Designation to Treat Autosomal Dominant Kidney Disease
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesNick rigopulosAllen davidoffDavid melamedVenture exchangeAmerican society of nephrologyDrug administrationTherapeutics incCompany xrxOrphan drug designationOrphan drugOrphan drug actAmerican societyKidney diseasePolycystic kidney diseaseNat rev dis

XORTX Therapeutics Inc (XRTX) Reports Positive Topline Results from XRX-OXY-101

XORTX Therapeutics Inc (XRTX) Reports Positive Topline Results from XRX-OXY-101
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesNick rigopulosAllen davidoffDavid melamedCompany xrxTherapeutics incVenture exchangeBridging pharmacokinetics clinical trialKidney diseasePolycystic kidney diseaseNat rev disNat rev nephrolForward looking

XORTX Announces Positive Topline Results from XRX-OXY-101 Clinical Trial

CALGARY, Alberta, Jan. 19, 2023 XORTX Therapeutics Inc. , a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is. | January 19, 2023

United statesNick rigopulosAllen davidoffDavid melamedCompany xrxTherapeutics incBridging pharmacokinetics clinical trialKidney diseasePolycystic kidney diseaseNat rev disNat rev nephrolXortx therapeutics inc stock exchangePress releaseIdney xrtx ca98420q2071